China's 98% control of gallium production, combined with escalating export restrictions and surging defense/semiconductor demand, creates a compelling investment thesis for companies with non-Chinese gallium exposure. Gallium prices have surged from ~$300/kg pre-restrictions to $2,060/kg (Rotterdam, January 2026)—a nearly 590% increase. While China temporarily suspended its export ban in November 2025 (through November 2026), structural supply vulnerabilities persist as the West races to establish alternative sources. This analysis identifies and ranks publicly-traded companies offering maximum leverage to gallium price appreciation.
Global primary gallium production reached 760 tonnes in 2024, with China controlling 98-99% of supply. The remaining non-China production comes from Japan (~3 tonnes), South Korea (~3 tonnes), and Russia (~6 tonnes)—collectively less than 2% of global output. The United States produces zero primary gallium and remains 100% import-dependent.
Gallium demand is concentrated in compound semiconductors: 79% goes to integrated circuits (GaAs/GaN wafers), 20% to optoelectronic devices, and the remainder to R&D. Defense applications drive strategic urgency—GaN enables next-generation AESA radars (LTAMDS, SPY-6, G/ATOR) that provide 5x higher power output than legacy GaAs systems and can double detection range with the same aperture.
China's export controls followed this timeline: licensing requirements announced July 2023, implemented August 2023 (exports collapsed from 7,000 kg monthly to near zero), complete US ban announced December 2024, then suspension announced November 2025 for one year. The suspension does not eliminate licensing requirements—it merely eases enforcement temporarily while structural risks remain. A critical chokepoint: China's Sunresin produces 90% of the chelating resin technology essential for cost-effective gallium extraction.
| Price Point | Historical Context | Supply Implications |
|---|---|---|
| $300/kg | Pre-2023 baseline | Normal market function |
| $500/kg | 2024 elevated levels | Capex payback ~2.5-3 years |
| $800/kg | Moderate shortage scenario | Compelling investment economics |
| $1,000/kg | Severe shortage scenario | Accelerates all non-China projects |
| $2,060/kg | Current Rotterdam (Jan 2026) | Extraordinary premium for non-China supply |
5N Plus is the most compelling publicly-traded gallium investment, offering direct exposure through high-purity gallium production (up to 7N/99.99999% purity) combined with strong financials and reasonable valuation. The Montreal-based company operates gallium chemicals plants in Madison, Wisconsin; Wellingborough, UK; and South Korea.
The company just reported record Q3 2025 results: revenue of $104.9 million (+33% YoY), adjusted EBITDA of $29.1 million (+86% YoY), and net earnings of $18.2 million. Full-year 2025 EBITDA guidance was raised to $85-90 million, implying a forward EV/EBITDA of ~14.9x. The backlog stands at $357.5 million—representing 311 days of annualized revenue—providing significant visibility.
5N Plus maintains a fortress balance sheet with net debt of just $63.3 million (0.74x net debt/EBITDA), providing ample capacity for expansion. The company operates a fully integrated closed-loop recycling system for gallium and other specialty metals, enabling both primary production and secondary recovery. Key customers include First Solar, defense contractors, and space industry players.
Bull case at $800/kg gallium: Revenue and margins expand further as gallium compounds command premium pricing; defense/space customers prioritize supply security over price. Potential EBITDA uplift of 40-60% from current levels. Trading at ~C$20.76 with analyst consensus pointing to 30-50% upside.
Primary risks: Chinese competition if export suspension becomes permanent; customer concentration; relatively small market cap may limit institutional interest.
AXT offers the highest direct leverage to gallium pricing as a pure-play GaAs, InP, and Ge substrate manufacturer—virtually 100% of revenue ties to gallium/germanium-based materials. The stock surged 92% over 12 months through December 2025, reflecting AI-driven demand for InP substrates in data center applications.
Q3 2025 showed dramatic improvement: revenue of $28 million (+56% QoQ, +18% YoY), with InP backlog hitting a record $49 million (doubled from Q2). GaAs revenue reached $7.5 million (+20% QoQ). The company raised $87 million in a December 2025 public offering, eliminating near-term liquidity concerns.
AXT's unique structure creates both opportunity and risk: the company owns partial stakes in 10 Chinese raw material companies, including JinMei (high-purity gallium producer). This provides cost-advantaged feedstock access within China but subjects exports to MOFCOM licensing requirements. In Q2 2025, significant shipment delays occurred due to permit issues, though export permits normalized in Q3.
Bull case at $800/kg gallium: InP demand for AI/data center connectivity continues explosive growth; export permits remain obtainable; Chinese domestic gallium access provides margin advantage versus Western competitors. 50-100%+ upside potential given extreme operating leverage.
Primary risks: All manufacturing in China; Beijing government instructed relocation of GaAs lines; germanium export permits "difficult to obtain"; 2.56 beta creates extreme volatility.
Alcoa operates the most advanced non-China gallium project, with a planned 100 tonnes/year facility at its Wagerup alumina refinery in Western Australia—approximately 10% of global production. The Joint Development Agreement with JAGA (Sojitz Corporation + JOGMEC) was signed August 2025, with final investment decision expected by end-2025 and commercial operations targeted for end of 2026.
Government support is substantial: $200 million in concessional equity finance from US and Australian governments, US Export-Import Bank letters of interest, and positioning within the $13 billion Australia-US critical minerals framework. Alcoa's three Western Australian refineries (Pinjarra, Wagerup, Kwinana) collectively process ~9.4 million tonnes of alumina annually, providing ample Bayer process liquor for gallium recovery.
At current trading (~7.4x EV/EBITDA with $15.7B enterprise value on $2.2B EBITDA), Alcoa assigns essentially zero option value to gallium. At 100 tonnes production and $800/kg pricing, gallium would contribute $80 million annually—representing 3.6% EBITDA uplift at current levels. At $1,000/kg, contribution reaches $100 million.
Bull case: Gallium project proceeds on schedule; prices remain elevated; government support de-risks execution; strategic positioning earns premium from defense customers. 20-30% upside from aluminum fundamentals plus gallium optionality.
Primary risks: Project execution delay; gallium prices normalize if China suspension becomes permanent; aluminum market cyclicality dominates equity performance.
Century Aluminum offers higher relative leverage to any byproduct recovery given its smaller market capitalization (~$3.8B) versus peers. The company operates US and Iceland smelters (~550,000+ tonnes/year) and majority-owns the Jamalco alumina refinery in Jamaica, which is currently restarting operations.
No gallium recovery plans are announced, but Jamaican bauxite contains 48-75 ppm gallium (average ~60 ppm)—among the higher concentrations globally. Should Century pursue gallium recovery at Jamalco, even modest production of 30 tonnes annually would contribute meaningfully: $24 million at $800/kg represents ~3.7% of EBITDA.
The company benefits from US domestic production positioning (45X tax credits) and potential tariff advantages. Stock is up substantially with Wells Fargo raising its target to $61 and Zacks upgrading to Strong Buy in January 2026.
Bull case: Management announces gallium recovery initiative at Jamalco; US critical minerals policy provides funding; aluminum tariffs protect domestic production. 25-40% upside driven by aluminum fundamentals with gallium optionality.
Primary risks: No announced gallium plans; Jamaica operations face execution challenges; balance sheet less robust than larger peers (~1.0x net debt/EBITDA).
Rio Tinto achieved its first gallium extraction in May 2025 through an R&D partnership with Indium Corporation at its Vaudreuil alumina refinery in Quebec—Canada's only alumina refinery. The demo plant targets up to 3.5 tonnes/year, with commercial-scale potential of 40 tonnes/year (5-10% of global production).
The Quebec government provides financial support, and Rio Tinto also partnered with Geomega Resources ($4.5M) to explore gallium recovery from bauxite residue. However, gallium is financially immaterial to Rio Tinto: at $53.7B revenue and $23.3B EBITDA, even $40M in gallium revenue represents <0.1% of the business.
Bull case: R&D success leads to commercial development; Canadian critical minerals policy provides support; gallium becomes part of broader critical minerals positioning alongside lithium (Arcadium acquisition). Limited gallium-specific upside but solid overall fundamentals.
Primary risks: Project remains in R&D phase with no committed timeline; financial immateriality limits management focus.
Korea Zinc (010130.KS) announced a $6.6 billion joint venture with the US Department of Defense for a Clarksville, Tennessee smelter that will produce 54 tonnes of gallium and 44 tonnes of germanium annually from 2030. The Pentagon will hold a 40% stake in the Crucible Metals JV, with $210 million in CHIPS Act funding committed.
Separately, Korea Zinc is building a $39M gallium plant in Ulsan, South Korea targeting 15.5 tonnes/year by 2028. Combined capacity of ~70 tonnes annually would make Korea Zinc a significant non-China producer.
The company trades on the KOSPI with limited Western investor access. For those able to invest, Korea Zinc represents the largest committed gallium expansion globally backed by unprecedented US government partnership.
Neo Performance operates the only industrial-scale gallium recycling facility in North America at its Peterborough, Ontario plant, producing "a few dozen tonnes" annually from semiconductor manufacturing scrap. The company can double production if feedstock availability improves.
Neo divested 80% of its Quapaw, Oklahoma gallium trichloride plant in January 2025 for $1.5M but retained a 7-year gallium supply/recycling agreement. The company is piloting technology with bauxite miners globally to develop virgin gallium sources.
Strategic interest from US and EU government officials since 2023 creates policy tailwind potential. However, gallium represents a small portion of overall revenue within the Rare Metals division.
Metlen's Greek project received EU Critical Raw Materials Act strategic project designation, targeting 50 tonnes/year by 2027 with a €295 million investment. The integrated BAUX-EU, GALLANT, and LEADER projects combine bauxite, alumina, aluminum, and gallium production.
This represents the largest committed European gallium project and benefits from EU funding access through the €22.5 billion strategic projects allocation.
MACOM is ideally positioned among compound semiconductor companies: US-based manufacturing, Category 1A DoD Trusted Foundry status, $70 million direct CHIPS Act funding (up to $180M total with state support), and defense customers representing 43% of revenue with 50%+ YoY growth in FY2025.
The company is investing $345 million over 5 years to modernize its Lowell, Massachusetts and Durham, North Carolina fabs, expanding 100mm GaN/GaAs and introducing 150mm GaN-on-SiC capability. Defense customers prioritize supply security over price, enabling MACOM to pass through gallium cost increases.
Trading at a premium (13.6x sales) reflects superior positioning, but pricing power and government support justify the valuation.
Qorvo operates internal GaN-on-SiC and GaAs fabs in the US with Manufacturing Readiness Level 10 (highest DoD rating). The company won Raytheon's Premier Award for four consecutive years, demonstrating deep defense integration.
Strong defense relationships provide pricing power for gallium cost pass-through, though mobile handset market cyclicality creates exposure. Trading at ~$10B market cap with very high gallium exposure (80%+ of products).
IQE operates GaAs/GaN epiwafer manufacturing in the UK, US, and Taiwan—strategic Western compound semiconductor capacity. However, financial stress (H1 2025 revenue down 31% YoY, operating loss of £33M in FY2024) led to a strategic review with potential sale of the company.
Trading at just £50 million market cap, IQE represents a distressed opportunity for strategic buyers seeking compound semiconductor capacity. The company received HSBC covenant waivers, indicating financial fragility.
Potential M&A target for defense primes or semiconductor companies seeking Western epiwafer supply.
American Resources owns 19% of ReElement Technologies, which filed patent applications for high-purity gallium refining (99.5%-99.999% purity) using Ligand Assisted Displacement chromatography. The company shipped first 99.999% pure gallium samples in June 2025 from recycled defense materials.
A $200 million strategic equity facility secured in January 2026 supports development of the Marion, Indiana "Supersite" targeting >10,000 MTPA refined critical minerals. However, financials reveal significant distress: FY2024 revenue of just $383K, negative $23.2M EBITDA, and auditor "substantial doubt" going concern warning with $75.7M negative working capital.
Bull case: Technology proves out; DOE partnerships provide validation; first-mover advantage in US domestic gallium refining. 3-5x+ potential.
Primary risks: Going concern warning; pre-revenue stage; unproven technology at commercial scale; execution risk.
Weighted scoring criteria: Existing gallium production (25%), Expansion potential/timeline (20%), Strategic positioning (15%), Non-China supply chain (15%), EBITDA leverage (10%), Financial capacity (10%), Valuation (5%).
| Rank | Company | Ticker | Score | Investment Thesis |
|---|---|---|---|---|
| 1 | 5N Plus | VNP.TO | 92 | Best pure-play: producing gallium, record financials, defense/space exposure |
| 2 | Alcoa | AA | 85 | Most advanced Western project, tri-government support, 100 t/yr by end 2026 |
| 3 | Korea Zinc | 010130.KS | 83 | $6.6B US JV, DoD 40% stake, 54 t/yr by 2030 |
| 4 | MACOM | MTSI | 78 | Defense focus, CHIPS Act support, pricing power |
| 5 | AXT Inc | AXTI | 75 | Pure GaAs/InP exposure, AI data center demand, China risks |
| 6 | Neo Performance | NEO.TO | 70 | Only North American recycler, can double capacity |
| 7 | Century Aluminum | CENX | 68 | Highest aluminum-sector leverage, US positioning |
| 8 | Qorvo | QRVO | 65 | Defense credentials, US fabs, RF semiconductor leader |
| 9 | Rio Tinto | RIO | 55 | R&D phase, massive company dilutes gallium impact |
| 10 | IQE plc | IQE.L | 52 | Western capacity but distressed, potential M&A |
| 11 | American Resources | AREC | 45 | Speculative: technology promising, financial stress |
At $800/kg sustained gallium pricing, the investment landscape transforms:
| Company | Gallium EBITDA Contribution | % of Total EBITDA | Stock Upside Potential |
|---|---|---|---|
| 5N Plus | ~$45-60M direct exposure | 50-70% | 40-60% |
| AXT Inc | Full margin expansion | 100%+ | 75-150% |
| Alcoa | $80M (100 tonnes) | 3.6% | 25-35% |
| Korea Zinc | $43M (54 tonnes US) | 2-3% | 20-30% |
| Century Aluminum | $24M (30 tonnes potential) | 3.7% | 30-45% |
| MACOM | Margin expansion (pass-through) | Indirect | 15-25% |
The payback period for new gallium recovery facilities falls to 1.5-2 years at $800/kg, making virtually all announced projects financially compelling and accelerating additional investment.
Near-term (Q1-Q2 2026): Alcoa FID on Wagerup gallium project; China MOFCOM license approval rates; DOE TRACE-Ga program awards; Metlen Greece construction progress.
Medium-term (2026-2027): Alcoa production startup (end 2026); Kazakhstan restart (H2 2026); Germany Stade restart (40 t/yr by 2027); Metlen Greece (50 t/yr by 2027); November 2026 expiration of China export suspension.
Structural: Defense modernization programs (LTAMDS, SPY-6, G/ATOR all use GaN); 5G/6G infrastructure buildout; EV power electronics adoption; AI/data center InP demand.
Highest conviction: 5N Plus (VNP.TO) offers the best risk-adjusted gallium exposure—profitable, growing, reasonable valuation, and direct production exposure. Position sizing: 5-8% of a critical minerals portfolio.
Core holdings: Alcoa (AA) provides large-cap exposure with defined project timeline and government support. MACOM (MTSI) captures downstream demand with pricing power. Combined position sizing: 10-15%.
Opportunistic: AXT Inc (AXTI) for aggressive investors comfortable with China execution risk and volatility. Century Aluminum (CENX) for domestic aluminum exposure with latent gallium potential. Position sizing: 3-5% each, understanding downside risk.
Speculative: American Resources (AREC) represents lottery ticket exposure to US domestic gallium production—position sizing 1-2% maximum with understanding of total loss potential.
The gallium investment thesis rests on structural supply concentration that took decades to develop and will require years to meaningfully diversify. Even with China's temporary suspension of export controls, Western governments recognize the strategic vulnerability and are committing billions to alternative supply development. Companies positioned to capture this reshoring trend offer asymmetric upside with government support reducing downside risk.